1
|
Graewert MA, Wilhelmy C, Bacic T, Schumacher J, Blanchet C, Meier F, Drexel R, Welz R, Kolb B, Bartels K, Nawroth T, Klein T, Svergun D, Langguth P, Haas H. Quantitative size-resolved characterization of mRNA nanoparticles by in-line coupling of asymmetrical-flow field-flow fractionation with small angle X-ray scattering. Sci Rep 2023; 13:15764. [PMID: 37737457 PMCID: PMC10516866 DOI: 10.1038/s41598-023-42274-z] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2023] [Accepted: 09/07/2023] [Indexed: 09/23/2023] Open
Abstract
We present a generically applicable approach to determine an extensive set of size-dependent critical quality attributes inside nanoparticulate pharmaceutical products. By coupling asymmetrical-flow field-flow fractionation (AF4) measurements directly in-line with solution small angle X-ray scattering (SAXS), vital information such as (i) quantitative, absolute size distribution profiles, (ii) drug loading, (iii) size-dependent internal structures, and (iv) quantitative information on free drug is obtained. Here the validity of the method was demonstrated by characterizing complex mRNA-based lipid nanoparticle products. The approach is particularly applicable to particles in the size range of 100 nm and below, which is highly relevant for pharmaceutical products-both biologics and nanoparticles. The method can be applied as well in other fields, including structural biology and environmental sciences.
Collapse
Affiliation(s)
| | - Christoph Wilhelmy
- Department of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg-University, Mainz, Germany
| | | | | | - Clement Blanchet
- European Molecular Biology Laboratory, Hamburg Unit, Hamburg, Germany
| | | | | | - Roland Welz
- Postnova Analytics GmbH, Landsberg am Lech, Germany
| | - Bastian Kolb
- Department of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg-University, Mainz, Germany
| | - Kim Bartels
- Department of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg-University, Mainz, Germany
| | - Thomas Nawroth
- Department of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg-University, Mainz, Germany
| | | | - Dmitri Svergun
- European Molecular Biology Laboratory, Hamburg Unit, Hamburg, Germany
- BIOSAXS GmbH, Hamburg, Germany
| | - Peter Langguth
- Department of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg-University, Mainz, Germany
| | - Heinrich Haas
- Department of Biopharmaceutics and Pharmaceutical Technology, Johannes Gutenberg-University, Mainz, Germany.
- BioNTech SE, Mainz, Germany.
| |
Collapse
|
2
|
Ambrosio E, Podmore A, Gomes dos Santos AL, Magarkar A, Bunker A, Caliceti P, Mastrotto F, van der Walle CF, Salmaso S. Control of Peptide Aggregation and Fibrillation by Physical PEGylation. Biomacromolecules 2018; 19:3958-3969. [DOI: 10.1021/acs.biomac.8b00887] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Elena Ambrosio
- Department of Pharmaceutical and Pharmacological Sciences, Università degli Studi di Padova, via F. Marzolo 5, 35131 Padova, Italy
| | - Adrian Podmore
- Formulation Sciences, MedImmune Ltd., Granta Park, Cambridge CB21 6GH, United Kingdom
| | | | - Aniket Magarkar
- Centre for Drug Research, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Helsinki FI-00014, Finland
| | - Alex Bunker
- Centre for Drug Research, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Helsinki FI-00014, Finland
| | - Paolo Caliceti
- Department of Pharmaceutical and Pharmacological Sciences, Università degli Studi di Padova, via F. Marzolo 5, 35131 Padova, Italy
| | - Francesca Mastrotto
- Department of Pharmaceutical and Pharmacological Sciences, Università degli Studi di Padova, via F. Marzolo 5, 35131 Padova, Italy
| | | | - Stefano Salmaso
- Department of Pharmaceutical and Pharmacological Sciences, Università degli Studi di Padova, via F. Marzolo 5, 35131 Padova, Italy
| |
Collapse
|
3
|
Boll B, Josse L, Heubach A, Hochenauer S, Finkler C, Huwyler J, Koulov AV. Impact of non-ideal analyte behavior on the separation of protein aggregates by asymmetric flow field-flow fractionation. J Sep Sci 2018; 41:2854-2864. [DOI: 10.1002/jssc.201701457] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2017] [Revised: 04/14/2018] [Accepted: 04/19/2018] [Indexed: 11/11/2022]
Affiliation(s)
- Björn Boll
- Analytical Development & Quality Control; Pharma Technical Development Biologics Europe; F. Hoffmann-La Roche Ltd.; Basel Switzerland
- Department of Pharmaceutical Sciences; Division of Pharmaceutical Technology; University of Basel; Basel Switzerland
| | - Lena Josse
- Analytical Development & Quality Control; Pharma Technical Development Biologics Europe; F. Hoffmann-La Roche Ltd.; Basel Switzerland
| | - Anja Heubach
- Analytical Development & Quality Control; Pharma Technical Development Biologics Europe; F. Hoffmann-La Roche Ltd.; Basel Switzerland
| | - Sophie Hochenauer
- Analytical Development & Quality Control; Pharma Technical Development Biologics Europe; F. Hoffmann-La Roche Ltd.; Basel Switzerland
| | - Christof Finkler
- Analytical Development & Quality Control; Pharma Technical Development Biologics Europe; F. Hoffmann-La Roche Ltd.; Basel Switzerland
| | - Jörg Huwyler
- Department of Pharmaceutical Sciences; Division of Pharmaceutical Technology; University of Basel; Basel Switzerland
| | - Atanas V. Koulov
- Analytical Development & Quality Control; Pharma Technical Development Biologics Europe; F. Hoffmann-La Roche Ltd.; Basel Switzerland
| |
Collapse
|